Pages that link to "Q79369066"
Jump to navigation
Jump to search
The following pages link to Clinical and immunopathologic findings during treatment of recalcitrant atopic eczema with efalizumab (Q79369066):
Displaying 4 items.
- New era of biologic therapeutics in atopic dermatitis (Q27001941) (← links)
- Contrasting pathogenesis of atopic dermatitis and psoriasis—Part II: Immune cell subsets and therapeutic concepts (Q37855007) (← links)
- My clinical experience with efalizumab in the Hospital of Conxo (Q40402666) (← links)
- [Off-label use of biologic agents in the treatment of dermatosis, part 2: etanercept, efalizumab, alefacept, rituximab, daclizumab, basiliximab, omalizumab, and cetuximab] (Q80516806) (← links)